Efficacy of hypericum extract Ws® 5570 compared with paroxetine in patients with a moderate major depressive episode-a subgroup analysis

被引：0
作者：
Holsboer-Trachsler, E. [1 ]
Seifritz, E. [2 ]
Hatzinger, M. [3 ]
机构：
[1] Univ Basel, Psychiat Clin UPK, Basel, Switzerland
[2] Univ Zurich, Hosp Psychiat, Dept Psychiat Psychotherapy & Psychosomat, Zurich, Switzerland
[3] Univ Basel, Psychiat Serv Solothurn, Solothurn, Switzerland
来源：
EUROPEAN PSYCHIATRY | 2017年 / 41卷
关键词：
D O I：
10.1016/j.eurpsy.2017.01.716
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
EV0386
引用
收藏
页码：S529 / S530
页数：2
相关论文
共 25 条
[21]   Efficacy of aripiprazole augmentation in Japanese patients with major depressive disorder: A subgroup analysis and Montgomery-Asberg Depression Rating Scale and Hamilton Rating Scale for Depression item analyses of the Aripiprazole Depression Multicenter Efficacy study [J].
Ozaki, Norio ;
Otsubo, Tempei ;
Kato, Masaki ;
Higuchi, Teruhiko ;
Ono, Hiroaki ;
Kamijima, Kunitoshi .
PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2015, 69 (01) :34-42
[22]   Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies [J].
Linda Stein Gold ;
Andreas Pinter ;
April Armstrong ;
Matthias Augustin ;
Petr Arenberger ;
Neil Bhatia ;
Morten Praestegaard ;
Lars Iversen ;
Adam Reich .
Dermatology and Therapy, 2023, 13 :2031-2044
[23]   Calcipotriene and Betamethasone Dipropionate PAD-Cream Demonstrates Greater Treatment Efficacy in Patients with Moderate-to-Severe Psoriasis Compared to Topical Suspension/Gel: A Subgroup Analysis of Two Phase 3 Studies [J].
Gold, Linda Stein ;
Pinter, Andreas ;
Armstrong, April ;
Augustin, Matthias ;
Arenberger, Petr ;
Bhatia, Neil ;
Praestegaard, Morten ;
Iversen, Lars ;
Reich, Adam .
DERMATOLOGY AND THERAPY, 2023, 13 (09) :2031-2044
[24]   LESSONS LEARNT FROM AN 8-WEEK RANDOMIZED, DOUBLE-BLIND, CONTROLLED, PARALLEL GROUPS STUDY ON THE EFFICACY AND SAFETY OF AGOMELATINE (25-50 MG/DAY ORALLY) COMPARED TO PLACEBO IN BIPOLAR I PATIENTS WITH A CURRENT MAJOR DEPRESSIVE EPISODE [J].
Boyce, P. ;
Yatham, L. ;
Picarel-Blanchot, F. ;
de Bodinat, C. .
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2018, 52 :137-137
[25]   Efficacy and safety of esketamine nasal spray in addition to standard of care in patients with major depressive disorder who have active suicidal ideation with intent: A subgroup analysis of the Asian cohort of ASPIRE I (a randomized, double-blind, placebo-controlled study) [J].
Hong, Jin Pyo ;
Malek, Akramul Zikri Abd ;
Li, Cheng-Ta ;
Paik, Jong-Woo ;
Sulaiman, Ahmad Hatim ;
Madriaga, Gilbert ;
Zhuo, Jianmin ;
Siggins, Sarah ;
Fu, Dong-Jing ;
Ju, Po-Chung .
ASIA-PACIFIC PSYCHIATRY, 2023, 15 (04)
123